NDC product
Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula
NDC 17312-477 · TRP Company
Key facts
| Product NDC | 17312-477 |
|---|---|
| Proprietary name | Com-Pare2 Dual Yeast Relief Plus |
| Nonproprietary name | Candida Albicans, Wood Creosote, Sodium Chloride, Sulphur |
| Substances | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, SULFUR |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC] |
| Marketing start | Apr 30, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: